Loteprednol Etabonate Ophthalmic Gel, 0.38% is a corticosteroid indicated for the treatment of post-operative inflammation and pain following ocular surgery. Budget 2025 Expectations: Pharma ...

VK2375 is being developed in both oral and subcutaneous formulations for the potential treatment of various metabolic disorders such as obesity. Viking Therapeutics (PRNewsfoto/Viking Therapeutics ...